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The activity of jatrogrossidione, the main diterpene .of Jatropha grossidentata and jatrophone from Jatropha 
isabellii was determined against Leishmania and Trypanosoma cruz¿ strains in vitro as well as against Leishmania 
amazonensis in vivo. Jatrogrossidione showed a strong in vifro leishmanicidal and trypanocidal activity with ICloo 
of 0.75 and 1.5-5.0 pglmL, respectively. Under similar conditions, the ICloo of glucantime, ketoconazole and 
pentamidine towards Leishmania strains were >loo, 50-100 and 1 pg/mL, respectively. The ICso of 
jatrogrossidione was ~0.25 pg/mL against amastigote forms of Leishrnania infecting macrophages, with toxicity 
a t  concentrations higher than 0.5 FglmL. 
BALBlc mice infected with L. amazonensis strain PH 8 were treated 24 h after infection with jatrogrossidione 
and jatrophone for 13 consecutive days. Jatrophone at 25 mglkglday subcutaneously administered was 
significantly active (pc0.05) against the virulent strain PH8 of L. amazonesis; it was more active than 
Glucantime at  112 mg Sb” per kg/day. Subcutaneous administration of jatrophone, however, proved to be too 
toxic under our assay conditions. Assays of single local treatment on the footpad infection 2 weeks after 
inoculation of .L amazonensis indicated that jatrogrossidione and jatrophone were inactive at  the selected doses. 
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jatrogrossidione; jatrophone. 
INTRODUCTION 
Leishmaniasis is a tropical disease endemic in south and 
Central America and caused by the protozoan Leishmania 
spp. The chemotherapy of leishmaniasis involves the use of 
pentavalent antimonials and amphotericin B, which are 
expensive, toxic and sometimes inefficient drugs (Croft, 
1988; Berman, 1988). Chagas’ disease, a South American 
disease, is caused by the protozoan Trypanosoma cruzi and 
affects 15-20 million people from Argentine to Mexico. 
The treatment of acute Chagas’ disease is performed with 
drugs such as nifurtimox and benznidazole, both of them 
toxic, with varying efficacy and with undesirable side 
effects. There is no effective cure for the chronic phase of 
the disease (WHO, 1991). 
New drugs for the treatment of these protozoal diseases 
are urgently required and the ethnomedicine of the South 
American Indians is a valuable source of plant candidates 
for pharmacological and chemical studies (Wright and 
Phillipson, 1990). 
Jatropha grossidentata Pax et Hoffm. (Euphorbiaceae) is 
a shrub known as ‘Caniroja’ by the Ayoreo Indians living in 
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the central-northern part of the Paraguayan Chaco. The 
powdered roots are smoked in shamanic practices 
(Schmeda-Hirschmann, 1993). In a preliminary screening, 
the petroleum ether and ethyl acetate extract of Caniroja . 
roots showed in vitro activity against ir: cruzi and Leishma- 
nia strains at 10 kg/mL. Several diterpenes have been 
isolated from the roots, the main compound being the 
rhamnofolane jatrogrossidione (Jakupovic er al., 1988; 
Schmeda-Hirschmann er al., 1992). Jarropha isabellii 
Muell. Arg. is known as ‘Yaguá rová’ in Eastern Paraguay. 
An infusion, decoction or macerate of the rhizomes is used 
in Paraguayan traditional medicine as an abortifacient as 
well as to treat rheumatism and human gout. 
The objective of this work was to assess the antiprotozoal 
activity of the diterpenes jatrogrossidione 1 and jatrophone 
2 (see Fig. 1) towards T cruzi and Leishmania strains. 
MATERIALS AND METHODS 
Plant material. Jatropha grossidentafa Pax et Hoffm. was 
collected in Campo Loro, Paraguayan Chaco, while Jatro- 
pha isabellii Muell. Arg. was gathered in Altos, 
Departamento Cordillera, Paraguay, in December 199 1. 
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Figure 1. 
Voucher herbarium specimens (Schmeda 1289 and 1594, 
respectively) have been deposited at the Department of 
Botany, Smithsonian Institution, Washington, D.C., USA as 
well as at the Herbario de la Universidad de Talca, Chile. 
The collections were identified by Stephen Smith (US). 
Extraction and isolation. Jatrogrossidione was extracted 
from J. grossidenrata roots as previously described (Jaku- 
povic er al., 1988; Schmeda-Hirschmann et al., 1992) and 
was identified by physical constants, high field NMR 
spectroscopy and direct comparison on TLC with an 
authentic sample. 
Jatrophone was isolated as the main diterpene from J. 
isabelliì rhizomes and was identified by spectroscopic 
methods and x-ray diffraction (Kupchan et al., 1970). 
Leishmanicidal activity. Culture and maintenance of the 
Leishmania. Parasite: Leishmania amazonensis strain 
MHOM/GF/84/CAY H- 142 was originally isolated at the 
French Guyana Institut Pasteur. Leishmania braziliensis 
strain MHOM/BR/75/M2903 and Leishmania chagasi 
strain MHOM/BR/74/PP75 were obtained from IBBA, a 
WHO reference laboratory. Strain identification was 
confirmed by isoenzyme analysis (Sauvain er al., 1993). 
Leishmania promastigotes were cultured in Novy, MacNeal 
and Nicolle medium with 10% heat inactivated fetal serum 
at 28 OC. 
In  vitro tests on promastigote cultures of Leishmania 
spp. J. grossidentata fractions, jatrogrossidione and jatro- 
phone were aseptically dissolved in liquid medium and 
DMSO and placed in 96-well microtitre plates (Flow 
Laboratories) to obtain final concentrations of 20, 10, 5, 3, 
1.5 and 0.75 yg/mL. The final DMSO concentration did not 
exceed O. 1 %. All assays were carried out in triplicate. Each 
cell was cultured with 50000 parasites at 27 OC. The 
activity of the samples was evaluated after 72 h by optical 
observation on a culture drop with an inverted phase 
microscope, by comparison with control cells (without 
extracts). Pentamidine was used as a positive control 
(Sauvain et al., 1993). 
In vitro test on the amastigote forms. Mouse peritoneal 
macrophages were obtained as described by Sauvain 
(1989). One million non-inflammatory macrophages were 
collected from each BALB/c mouse. The adherent cells 
were placed at 37 OC under 5% COz for 2 h. The plates were 
then washed with RPMI-tbuffer (MOPS-Sigma, USA), 
without FCS to eliminate non-adherent cells. The super- 
natant was replaced by 0.5 mL/well of fresh RPMI 
medium+glutamine+FCS+antibiotics (100 IU penicillin 
and 100 yg streptomycin/mL) before infection by L. 
amazonensis amastigotes at a ratio of infecting organism to 
host cells of 5: 1. Infection took place at 34°C for a 
minimum of 2 h. Compounds were then added to the culture 
maintained at 37°C under 5% CO, for 24 h. The medium 
was then renewed and the cells left to incubate for another 
24 h before fixation. Plates were fixed with methanol and 
stained with 10% Giemsa’s stain (CML, France). They were 
set up with Eukitt Resin (CML, France). Macrophages with 
and without parasites were counted under x40 magnifica- 
tion. For each triplicate assay, the survival index (SI) of 
amastigotes was calculated relative to the control. 
In vivo test procedure. Eight-week-old BALB/c mice, 
2042 g, n= 10 for each random group (IFFA Credo, France) 
were infected with 2.5 x IO’ amastigotes of L. amazonensis 
(PH 8 strains) in one posterior foot (Trotter et al., 1980). 
Growth of cutaneous lesions was monitored for 8 consec- 
utive weeks, by measuring the diameter of the infected feet 
with a vernier caliper (Kroelin 10DIOOT6) at weekly 
intervals. Results were compared with those obtained with 
N-methylglucamine antimoniate (Glucantime). For each 
experiment, the mean of the difference between the infected 
foot and the normal foot was calculated with standard error 
of the mean. 
Mice in the first experiment were treated by the 
subcutaneous route. N-methylglucamine antimoniate was 
given at a dose of 112 mg of Sb” per kg of body weight daily 
and jatrogrossidione and jatrophone were given at 25 mg/ 
kg/day for 13 days. The compounds were dissolved in 
75 pL of RPMI 1640 and 25 pL of DMSO. Drug treatment 
commenced 1 day after the inoculation of amastigotes and 
was continued once daily for 13 days. In the second 
experiment, the treatment of mice started 2 weeks after 
infection by a single intralesional injection. For this 
experiment, mice were treated with N-methylglucamine 
antimoniate at 112 mg of Sb” per kg and with the diterpene 
at 50, 25 and 12.5 mg/kg. The Student’s t-test with the 
program STAVIEW was used for the statistical analysis of 
the 14 day assay ( ~ ~ 0 . 0 5 ) .  
Trypanocidal activity. Parasite: Trypanosoma cruzi strains 
Tulahuen, C8CL1, 1979CL1 and YC12 were used. The 
strains were obtained from IBBA and the identification was 
confirmed by isoenzyme analysis. T. cruzi epimastigotes 
were cultured in LIT (liver infusion tryptose) medium 
supplemented with 10% fetal calf serum at 28 “C with an 
inoculum of lo6 cells/mL. Samples (4 mg) were aseptically 
dissolved in 50 yL DMSO and liquid medium to obtain 
final concentrations of 20, 10,5,3, 1.5 and 0.75 yg/mL. All 
assays were carried out in triplicate. Final DMSO concen- 
tration was less than 0.5%. Parasites were counted after 48 h 
of contact with the samples in a haemocytometer and the 
activity of the test substances was assessed by comparison 
with controls (without extract) and with nifurtimox contain- 
ing cells (Foumet et al., 1988b). 
RESULTS ANDDÏSCUSSIÖN 
~ ~~ ~ 
The petroleum ether and ethyl acetate extracts of Jatropha 
grossidentara roots showed a significant activity against 
Leishmania promastigotes and í? cruzi epimastigotes in 
vitro. Bioassay-guided isolation identified jatrogrossidione 
as the main active J. grossidentata compound. Jatrogrossi- 
dione 1 and jatrophone 2 were quite active towards 
Leishmania promastigotes, showing IC,, of 0.75 yg/mL 
and 5 yg/mL, respectively, and similar activities against the 
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Table 1. In vitro activity of jatrogrossidione, jatrophone and 
selected reference compounds on Leishmania (pglmL, 
IC,,,,,) and Z cruzi (IC, pg/mL) 
L braziliensis L. amazonensis L. chagasi 
IC,, 2903 H-142 PP75 
Jatrogrossidione 0.75 0.75 0.75 
Jatrophone 5 5 5 
Glucantime >loo >loo >loo 
Ketoconazole 50 50 1 O0 
Pentamidine 1 1 1 
T: cruzi Tulahuen CBCLI 1979 YC12 
Nifurtimox 25 25 50 25 
Benznidazole 50 100 25 25 
Jatrogrossidione 1.5 e5 <5 c5 
Tulahuen strain of Trypanosoma cruzi (Table 1). Under 
similar conditions, the IC,, of the reference compounds 
glucantime, ketoconazole and pentamidine were > 100, 50 
and 1 pg/mL, respectively (see Table 1). 
Compound 1 is a diterpene belonging to the rhamnofo- 
lane type while jatrophone 2 is a jatrophane macrocycle, 
previously isolated from Jatropha gossypiifolia (Kupchan et 
al., 1970). Acetylation of 1 sharply reduced the trypanocidal 
effect, the compound being active at concentrations 
Jatrogrossidione was active at 0.5 pg/mL against the 
amastigote forms of Leishmania infecting macrophages, 
with a reduced toxicity towards the host cells (macro- 
phages) (Table 2). The in vivo activity of diterpenes 1 and 2 
was evaluated against BALB/c mice infected with L. 
amazonensis strain PH 8. The compounds were admin- 
istered subcutaneously at 25 mg/kg/day for 13 days. The 
LD,, was previously assessed for each diterpene by 
intraperitoneal injection. Results of this in vivo model are 
presented in Table 3. Jatrophone significantly reduced the 
diameter of lesions compared with control mice at weeks I, 
2,3,4 and 6 ( ~ ~ 0 . 0 5 ) .  Moreover, the lesions of jatrophone- 
treated mice were smaller than those treated with 
Glucantime. However, half of the mice receiving jatrophone 
at 25 mg/kg/day died during the experiment. In mice 
treated with a single intralesional injection in the infected 
footpad after inoculation of L. amazonensis, jatrogrossi- 
dione and jatrophone did not show statistically significant 
effects at 25 mg/kg (Table 4). The toxicity of jatrophone 
renders this diterpene unsuitable for use in the chemother- 
apy of leishmaniasis. Structure/activity relationships studies 
of jatrophone and their derivatives are necessary to identify 
compounds with reduced toxicity and increased leishmani- 
>loo p,g/mL. 
Table 2. In vitro activity of jatrogrossidione and the most 
active J. grossidentata fraction on L amazonensis 
amastigotes compared with their toxicity towards 
macrophages 
Dose (pglml) 
1 .o 0.5 0.25 0.125 
Fraction 12 
Survival of 
amastigotes, SI% 7 81 87 
Viability of 
macrophages % 95 98 
Jatrogrossidione 
Survival of 
amastigotes, SI% O O 2 62 
- 
- - 
Viability of 
Viability %, mean percentage of surviving macrophages. 
SI%, percentage survival of intracellular amastigotes. 
macrophages % 74 91 1 O0 
Table 3. Effect of N-methylglucamine antimonate (Glucan- 
time) at 112 mg Sb" per kglday, jatrogrossidione and 
jatrophone at 25 mglkglday on the development of L 
amazonensis P H 8  in BALB/c mice (diameter of 
IesionkSEM). Treatments were given for 13 days 
starting 1 day after inoculation of L amazonensis 
Diameter of lesion 
Jatrogrossidione Jatrophone Glucantime Untreated 
Weeks post-infection 
1 0.7520.09 0.1620.05' 0.4820.25 0.9320.37 
2 1.9420.41 0.2820.08* 1.4820.40' 2.11 20.48 
3 3.16 2 0.49 1.302 0.21 a 2.58 20.43' 3.27 i: 0.71 
4 4.1950.73 2.4020.27' 3.6820.45' 4.3420.73 
5 5.5920.90 3.8820.19 4.9220.80" 5.6521.11 
6 6.645 0.81 5.082 0.40' 6.35 2 0.91 6.45 2 1.1 3 
7 7.89 5 1.1 O 7.022 0.40 7.622 0.98 8.07 2 0.66 
8 9.01k1.38 8.7020.29 8.7320.75 8.5150.81 
N 8 5 10 10 
N number of animals surviving the assay. 
pe0.05. 
cidal effects in vivo. 
Several natural products have been reported as displaying 
antiprotozoal activity towards i? cruzi and Leishmania. In a 
study of the antiparasitic effects of bisbenzylisoquinoline 
alkaloids, daphnandrine, gyrocarpine and obaberine were 
active towards Leishmania and i? cruzi strains, with 
IC,,>50 p.g/mL (Foumet er al., 1988a, 1988b). The same 
authors (1992) report the in vitro effect of Pera benensis 
naphthoquinones against the promastigote and epimastigote 
forms of i? cruzi and the amastigote form of Leishmania as 
well as of 2-substituted quinoline alkaloids on T. cruzi and 
Leishmania, with IC,, (pg/mL) between 25 and 100 p,g/mL 
(Foumet et al., 1993a). Sauvain et al. (1993) reported the 
effect of ursolic acid and jacaranone from Jacaranda copaia 
on Leishmania, with ED,, of 0.02 mM in vitro and weak in 
vivo activity. 
Dehydrozaluzanin C inhibited in vitro the growth of 12 
Leishmania and 15 i? cruzi strains with IC, between 2.5 
Table 4. Effect of N-methylglucamine antimonate at 112 mg of 
Sb' per kglday, jatrogrossidione and jatrophone at 50, 
25 and 12.5 mg/kg/day on the development of L 
amazonensis PH8 in BALBlc mice (diameter of 
lesion+SEM). Treatments were given on the infected 
footpad with a single intralesional injection 14 days 
after the inoculation of L amazonensis 
Dose Imglkg) 50 25 12.5 200 
Weeks post-infection 
1 1.2120.53 1.2650.28 1.2920.23 0.9020.32 
2 2.9620.44 2.6420.52 2.4420.37 1.8350.37 
3 3.9920.57 3.7120.56 3.7120.53 3.0520.46 
4 5.3420.59 5.1320.68 5.0420.57 3.8520.82 
5 6.9020.72 6.7420.93 6.9221.00 5.5420.66 
6 7.8820.88 7.3920.78 8.0320.81 6.8920.70 
7 9.2920.71 7.5820.78 9.5450.80 8.6620.74 
a 10.2320.72 7.602 1.00 9.0720.96 9.4420.46 
. 
Jatrogrossidione Glucantime 
Jatrophone Untreated 
Dose Imglkg 50 25 12.5 
1 1.302 0.25 1.10 2 0.1 6 1.1 420.1 5 1.232 0.17 
2 3.0120.28 2.4920.21 2.3820.23 2.6620.20 
3 3.6020.63 3.4920.36 3.4720.32 4.0320.29 
4 4.7720.61 4.6620.63 4.3520.90 5.4920.39 
5 6.2220.82 6.0220.71 6.3720.63 6.5320.69 
6 7.3420.88 7.4620.81 7.31 20.31 7.3320.43 
7 8.8921.07 9.1420.62 8.6120.58 7.3120.91 
8 9.8020.58 9.5920.70 9.2320.75 8.0621.01 
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and 50 pg/mL. Under the same' experimental conditions, 
pentamidine and ketoconazole showed IC, of 0.5-2.5 and 
50-, 100 , , . g /m~ ,  respectively (Foumet et al., 1993b). A 
and isolated compounds has been published by Iwu et d. 
(1994). 
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